King Hussein Cancer Center


In June of 2013, Princess Margaret Cancer Centre and the King Hussein Cancer Center (KHCC), in Amman, Jordan, signed a Memorandum of Understanding (MOU) which initiated discussions about an international partnership and shared vision of delivering advanced, world-class cancer care.
"This is an opportunity to share expertise in clinical research, support innovation in cancer education programs and collaborate on future research projects that will benefit cancer patients on a global scale," said Dr. Mary Gospodarowicz, Medical Director, Princess Margaret Cancer Centre.
At a public ceremony hosted at The Princess Margaret, the two internationally acclaimed cancer centres signed the MOU establishing the principal areas of focus for the partnership: working together to enhance academic and research opportunities at both organizations, sharing best practices in cancer care diagnostics and therapeutics, exploring joint ventures in clinical practice and promoting e-health and new distance education initiatives.
Signing the MOU on behalf of the Princess Margaret Cancer Centre was Dr. Robert Bell, President and CEO of University Health Network and Dr. Mary Gospodarowicz, Medical Director of The Princess Margaret’s cancer program. Signing on behalf of the King Hussein Cancer Center and Foundation was Her Royal Highness, Princess Dina Mired.
"Our organizations have a common purpose and vision," said Dr. Bell. "That is to share best practices in all aspects of cancer care and research which inform tomorrow's clinical practice. This MOU says that we will support each other's efforts in achieving global impact and delivering the best care possible to our patients." 
About the King Hussein Cancer Center (KHCC)
The King Hussein Cancer Center (KHCC) is the only specialized cancer center in the Middle East treating both adult and pediatric patients. Founded in 1997, KHCC is a non-governmental, not-for-profit comprehensive center dedicated entirely to cancer care. It has a capacity of 148 beds and currently treats more than 2,300 new patients per year.